Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!
Abstract
Non-vitamin k antagonist oral anticoagulants (NOACs) are drugs of choice for the majority of patients with atrial fibrillation (AF) to prevent cerebral strokes (1). The risk for stroke in AF patients is determined by concomitant clinical factors, which are summarized in the CHA2DS2-Vasc risk score...
Paper Details
Title
Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!
Published Date
Dec 1, 2019
Volume
7
Issue
S8
Pages
S270 - S270
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History